There are 2789 resources available
1430P - Frequency of PD-L1 positivity and microsatellite instability (MSI) in the DANTE trial: Perioperative atezolizumab with FLOT versus FLOT alone in patients with resectable esophagogastric adenocarcinoma. A randomized, open-label phase IIb trial of the German gastric group at the AIO and SAKK
Presenter: Christina Kopp
Session: ePoster Display
1431P - Descriptive analysis and prognostic factors of microsatellite instability (MSI) gastric cancer patients (pts) compared to microsatellite stable (MSS) pts in a tertiary hospital
Presenter: Oriol Mirallas
Session: ePoster Display
1432P - Characterizing diversity in the immune profile by a transcriptomic customized gene signature to potentially personalize treatment in advanced gastric cancer patients
Presenter: Manuel Cabeza-Segura
Session: ePoster Display
1358P - Phase I dose-escalation study to evaluate safety and clinical activity of c-MET inhibitor ABN401 in patients with advanced solid tumor
Presenter: Dae Ho Lee
Session: ePoster Display
1438TiP - INTEGRATE IIb: A randomised phase III open label study of regorafenib + nivolumab vs standard chemotherapy in refractory advanced gastro-oesophageal cancer (AGOC)
Presenter: Nick Pavlakis
Session: ePoster Display
1368TiP - EPROPA: The European program for routine testing of patients with advanced lung cancer
Presenter: Francesco Passiglia
Session: ePoster Display